Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Vaping Products Labelling and Packaging Regulations (SOR/2019-353)

Regulations are current to 2020-05-17 and last amended on 2019-12-25. Previous Versions

PART 2Labelling and Packaging — Protection of Human Health or Safety (continued)

Purpose

The following provision is not in force.

Marginal note:Requirements — Canada Consumer Product Safety Act

 For the purposes of section 6 of the Canada Consumer Product Safety Act, this Part sets out requirements that must be met by vaping products that are consumer products.

Exception

The following provision is not in force.

Marginal note:Importation to bring into compliance or to export

  • The following provision is not in force.

     (1) A person may import a vaping product that does not comply with a requirement of this Part for the purpose of

    • The following provision is not in force.

      (a) bringing the product into compliance with the requirement;

    • The following provision is not in force.

      (b) reselling the product to a manufacturer in Canada that will bring it into compliance with the requirement; or

    • The following provision is not in force.

      (c) exporting the product to another country.

  • The following provision is not in force.

    Marginal note:Credible evidence

    (2) A person that imports a vaping product for a purpose described in subsection (1) must, on the request of an inspector, provide credible evidence to the inspector that it is being brought into compliance or is being exported.

Requirements

List of Ingredients

The following provision is not in force.

Marginal note:Contents

  • The following provision is not in force.

     (1) A list of ingredients is required for every vaping substance and must set out the common name, without abbreviation, of each ingredient that is present in the vaping substance. The list must begin with the title “Ingredients:” in the English version of the list and the title “Ingrédients :” in the French version of the list.

  • The following provision is not in force.

    Marginal note:List of ingredients — “flavour”

    (2) If any ingredients or combination of ingredients are added to a vaping substance solely to produce a particular flavour or combination of flavours, instead of being denoted in the list of ingredients by their common names, those ingredients must be denoted by the indication “flavour” in the English version of the list and “arôme” in the French version of the list.

The following provision is not in force.

Marginal note:List of ingredients — placement

  • The following provision is not in force.

     (1) Subject to subsections (2) and (3), the list of ingredients must be displayed on the display surface of the immediate container of the vaping substance and on the display surface of any exterior package.

  • The following provision is not in force.

    Marginal note:Exception — vaping device and vaping part

    (2) If the immediate container is a vaping device or vaping part and it is not packaged, the list of ingredients must be displayed on a tag attached to the vaping device or vaping part, as the case may be.

  • The following provision is not in force.

    Marginal note:Exception — size of main display panel

    (3) If the main display panel of the immediate container has an area of less than 45 cm2, the list of ingredients must be displayed on the display surface of the exterior package or a tag attached to the immediate container.

The following provision is not in force.

Marginal note:Maximum nicotine concentration

 A vaping product must not contain nicotine in a concentration of 66 mg/mL or more.

Child-Resistant Containers

The following provision is not in force.

Marginal note:Requirement — child-resistant container

  • The following provision is not in force.

     (1) Every immediate container that is a vaping device or vaping part, as well as every other immediate container that contains a vaping substance that has a nicotine concentration of 0.1 mg/mL or more, must meet the requirements set out in section 51 for a child-resistant container.

  • The following provision is not in force.

    Marginal note:Exception

    (2) Subsection (1) does not apply if exposure to a vaping substance that is in a form other than an aerosol is impossible during the reasonably foreseeable use of the container.

The following provision is not in force.

Marginal note:Applicable standard

  • The following provision is not in force.

     (1) A child-resistant container must

    • The following provision is not in force.

      (a) be constructed so that it can be opened only by operating, puncturing or removing one of its functional and necessary parts using a tool that is not supplied with the container; or

    • The following provision is not in force.

      (b) meet the child test protocol requirements of one of the following standards or a standard that is at least equivalent:

      • (i) the Canadian Standards Association Standard CAN/CSA Z76.1-16, entitled Reclosable child-resistant packages, as amended from time to time,

      • (ii) the International Organization for Standardization Standard ISO 8317:2015, entitled Child-resistant packaging — Requirements and testing procedures for reclosable packages, as amended from time to time, or

      • (iii) the United States Code of Federal Regulations, Title 16: Commercial Practices, section 1700.20, entitled “Testing procedure for special packaging”, as amended from time to time.

  • The following provision is not in force.

    Marginal note:Amended standard

    (2) Despite paragraph (1)(b), if a person has applied the child test protocol requirements of one of the standards referred to in that paragraph to a child-resistant container, as the standard read immediately before the day on which an amended version of that standard is published, the person may continue to apply those requirements to the child-resistant container during the period of 180 days after the day on which the amended standard is published.

The following provision is not in force.

Marginal note:Maintain characteristics

 A child-resistant container must maintain the characteristics of a child-resistant container throughout the useful life of the vaping substance that is placed in it, or in the case of a refillable container, throughout its useful life, under normal conditions of storage, sale and use.

The following provision is not in force.

Marginal note:Evaluation

  • The following provision is not in force.

     (1) The responsible person, using good scientific practices, must evaluate

    • The following provision is not in force.

      (a) the compatibility of the vaping substance with its child-resistant container to determine that the chemical or physical properties of the substance will not compromise or interfere with the proper functioning of the container; and

    • The following provision is not in force.

      (b) the physical wear and stress factors and the force required for opening and closing the container to determine that the proper functioning of the container will be maintained for the number of openings and closings reasonably foreseeable for the size and contents of the container.

  • The following provision is not in force.

    Marginal note:Definitions

    (2) The following definitions apply in this section.

    good scientific practices

    good scientific practices means

    • The following provision is not in force.

      (a) for the development of test data, conditions and procedures that are in accordance with or equivalent to those set out in the Organisation for Economic Co-operation and Development document entitled OECD Guidelines for the Testing of Chemicals, as amended from time to time;

    • The following provision is not in force.

      (b) for laboratory practices, practices that are in accordance with the principles set out in the Organisation for Economic Co-operation and Development document entitled OECD Principles of Good Laboratory Practice, Number 1 of the OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring, as amended from time to time; and

    • The following provision is not in force.

      (c) for human experience data, a peer-reviewed study of clinical cases. (bonnes pratiques scientifiques)

    human experience data

    human experience data means data, collected in accordance with good scientific practices, that demonstrates that injury to or poisoning of a human has or has not resulted from

    • The following provision is not in force.

      (a) exposure to a vaping substance; or

    • The following provision is not in force.

      (b) the reasonably foreseeable use of a vaping substance or immediate container by a consumer, including by a child. (données de l’expérience humaine)

 
Date modified: